Lam Research Corporation $LRCX Stock Holdings Cut by Formuepleje A S

Formuepleje A S cut its position in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 51.6% during the 2nd quarter, Holdings Channel reports. The firm owned 7,565 shares of the semiconductor company’s stock after selling 8,075 shares during the period. Formuepleje A S’s holdings in Lam Research were worth $3,278,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of LRCX. World Equity Group Inc. boosted its stake in Lam Research by 0.5% during the second quarter. World Equity Group Inc. now owns 5,576 shares of the semiconductor company’s stock valued at $2,416,000 after buying an additional 29 shares in the last quarter. Tenzing Financial LLC raised its position in Lam Research by 3.5% in the second quarter. Tenzing Financial LLC now owns 1,018 shares of the semiconductor company’s stock worth $441,000 after acquiring an additional 34 shares in the last quarter. Advus Financial Partners LLC lifted its holdings in Lam Research by 1.0% in the 2nd quarter. Advus Financial Partners LLC now owns 3,578 shares of the semiconductor company’s stock valued at $1,550,000 after acquiring an additional 34 shares during the last quarter. Paragon Private Wealth Management LLC lifted its holdings in Lam Research by 1.3% in the 2nd quarter. Paragon Private Wealth Management LLC now owns 2,719 shares of the semiconductor company’s stock valued at $1,178,000 after acquiring an additional 35 shares during the last quarter. Finally, Gibraltar Capital Management Inc. boosted its position in shares of Lam Research by 3.6% during the 2nd quarter. Gibraltar Capital Management Inc. now owns 1,050 shares of the semiconductor company’s stock valued at $455,000 after purchasing an additional 36 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Insider Activity

In other news, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director owned 199,205 shares in the company, valued at $69,881,114. This represents a 21.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Talwalkar sold 18,282 shares of the stock in a transaction that occurred on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares of the company’s stock, valued at $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 77,782 shares of company stock worth $26,755,370 in the last 90 days. Company insiders own 0.31% of the company’s stock.

Lam Research Price Performance

LRCX opened at $307.65 on Monday. The stock has a fifty day moving average of $321.34 and a 200-day moving average of $291.79. The firm has a market capitalization of $384.97 billion, a P/E ratio of 53.41, a PEG ratio of 1.22 and a beta of 1.85. Lam Research Corporation has a 12-month low of $100.68 and a 12-month high of $438.50. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. The business had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.Lam Research’s revenue for the quarter was up 30.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities analysts forecast that Lam Research Corporation will post 9.33 EPS for the current fiscal year.

Lam Research Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Shareholders of record on Wednesday, September 23rd will be paid a dividend of $0.33 per share. This is a boost from Lam Research’s previous quarterly dividend of $0.26. The ex-dividend date of this dividend is Wednesday, September 23rd. This represents a $1.32 annualized dividend and a yield of 0.4%. Lam Research’s dividend payout ratio (DPR) is presently 18.06%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on LRCX shares. Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. B. Riley Financial reduced their target price on shares of Lam Research from $385.00 to $350.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Jefferies Financial Group set a $335.00 price target on shares of Lam Research and gave the stock a “buy” rating in a research report on Thursday, July 30th. Bank of America upped their price target on Lam Research from $330.00 to $480.00 and gave the company a “buy” rating in a report on Tuesday, June 23rd. Finally, Barclays reiterated an “overweight” rating and set a $335.00 price objective (up from $275.00) on shares of Lam Research in a research report on Thursday, June 11th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.97.

Read Our Latest Stock Analysis on LRCX

More Lam Research News

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
  • Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
  • Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
  • Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
  • Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
  • Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
  • Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.